Welcome to our dedicated page for Amedisys news (Ticker: AMED), a resource for investors and traders seeking the latest updates and insights on Amedisys stock.
Amedisys Inc. (NASDAQ: AMED) is a leading healthcare services company in the United States, specializing in delivering personalized home health, hospice, and high-acuity care services. Headquartered in Baton Rouge, LA, with an executive office in Nashville, TN, the company employs around 18,700 staff across 520 care centers in 37 states and the District of Columbia. Founded in 1982, Amedisys is dedicated to providing quality, clinically-distinctive care to more than 469,000 patients annually, with over 10.6 million visits each year.
Amedisys operates across four key segments: Home Health, Hospice, High Acuity Care, and Personal Care. The Home Health segment offers skilled nursing, therapy, and aid services directly in patients' homes, while the Hospice segment provides end-of-life care to terminally ill patients. The High Acuity Care segment delivers critical inpatient care elements at home, and the Personal Care segment, which was divested in March 2023, offered assistance with daily living activities.
Amedisys's commitment to high-quality care is underpinned by its comprehensive coordination with healthcare providers and personalized care plans tailored to each patient's unique needs. With a strong network involving more than 3,000 hospitals and 110,000 physicians nationwide, Amedisys is a trusted partner in post-acute care.
Recent notable achievements include a merger agreement with UnitedHealth Group, aimed at enhancing patient care through integrated services. Financially, Amedisys reported a net service revenue increase to $571.4 million for Q1 2024, reflecting a robust service demand despite divesting the Personal Care segment.
Additionally, Amedisys is actively involved in advancing healthcare technology. The company has partnered with Patient Choice Laboratories to incorporate advanced molecular testing, enhancing infection diagnosis and patient outcomes. This innovation underscores Amedisys’s commitment to leveraging cutting-edge technology to improve patient care.
For stakeholders, Amedisys remains a prominent figure in the home healthcare industry, constantly adapting and growing to meet the increasing needs of its patient population. The company's strategic partnerships and advancements in healthcare technology position it well for sustained growth and improved patient outcomes.
Amedisys, Inc. (NASDAQ: AMED) reported Q1 2022 financial results, showing a net service revenue increase of $8.2 million to $545.3 million but a decline in net income to $31.7 million from $49.9 million in 2021. Adjusted EBITDA was $66.3 million versus $78.6 million in the prior year. The company's guidance for 2022 includes anticipated adjusted revenue between $2.330 billion to $2.365 billion and adjusted diluted earnings per share of $5.23 to $5.45. CEO Chris Gerard highlighted challenges due to COVID-19 but expressed confidence in growth opportunities.
Amedisys, Inc. (NASDAQ: AMED) has promoted Nick Muscato to Chief Strategy Officer, effective immediately. Muscato has significant experience in the company, previously serving as Senior Vice President of Finance, and has been instrumental in developing the company's strategic direction. His efforts in Investor Relations have strengthened relationships with analysts and shareholders. Muscato expressed enthusiasm for continuing to enhance Amedisys’ mission of providing home-based healthcare services and improving patient care.
Amedisys, Inc. (NASDAQ: AMED) will announce its first-quarter results for the period ending March 31, 2022, after market hours on April 27, 2022. The company plans to host an investor conference call the following day at 11:00 a.m. ET to discuss these results. Interested participants can join the call via toll-free numbers or through the company's website. Amedisys specializes in home health, hospice, personal care, and high-acuity care, serving over 445,000 patients annually with more than 11.5 million visits in 38 states.
Amedisys, Inc. (NASDAQ: AMED) has acquired home health assets from AssistedCare Home Health and RH Homecare Services, enhancing its service offerings in North Carolina. This acquisition allows Amedisys to extend both home health and hospice services into new communities, particularly Wilmington and Greenville. With this addition, Amedisys operates 350 care centers across 34 states, serving around 74,000 patients daily. The company emphasizes its commitment to quality, holding a QPC Star score of 4.33 and recognition as a top workplace in healthcare.
Amedisys has successfully acquired Evolution Health, enhancing its home health services footprint across Texas, Oklahoma, and Ohio. This acquisition allows Amedisys to operate under established local brands like Guardian Healthcare, expanding care options to more communities. The company now boasts 350 care centers across 34 states, servicing roughly 74,000 patients daily. Amedisys ranks as the second-largest home health provider and third-largest hospice provider in the U.S., with a commendable Quality of Patient Care (QPC) Star score of 4.33.
Amedisys, a prominent provider of home health and hospice services, will present at Oppenheimer’s 32nd Annual Healthcare Conference on March 16, 2022, at 10:40 a.m. EST, followed by the Barclays Global Healthcare Conference on March 17, 2022, at 8:00 a.m. EST. Key executives Chris Gerard and Scott Ginn will lead the presentations. Investors can access the live webcasts on Amedisys’ official website. With over 21,000 employees and 530 care centers across 38 states, Amedisys serves more than 445,000 patients annually, conducting over 11.5 million visits each year.
Amedisys, Inc. (NASDAQ: AMED), a prominent provider of home health and hospice services, announced its participation in the Raymond James & Associates' 43rd Annual Institutional Investors Conference. Chris Gerard, President and COO, along with Scott Ginn, CFO, will present on March 8 at 11:35 a.m. EST. Interested individuals can access the live webcast through Amedisys' investor relations website. The company, founded in 1982 and based in Baton Rouge, serves over 418,000 patients annually with a workforce of approximately 21,000 employees across 529 care centers in 38 states.
Amedisys, Inc. (NASDAQ: AMED) reported Q4 2021 net service revenue of $559.3 million, up $8.6 million from Q4 2020. However, net income decreased to $34.0 million, or $1.04 per diluted share, down from $45.2 million, or $1.36, in the previous year. For the full year, revenue climbed to $2,214.1 million, with net income rising to $209.1 million. The company anticipates 2022 adjusted net service revenue between $2.330 billion and $2.365 billion, amid ongoing COVID-19 impacts. The CEO expressed optimism about future growth opportunities as the company adapts to evolving healthcare needs.
Virginia Mason Franciscan Health has partnered with Contessa, an Amedisys company (NASDAQ: AMED), to launch Home Recovery Care, enabling patients to receive hospital-level care at home. This initiative aims to enhance access to high-acuity care, increase inpatient capacity, and lower overall healthcare costs. The program, starting at St. Joseph Medical Center in Tacoma, will initially serve Medicare fee-for-service patients and includes remote monitoring, nursing visits, and telehealth consultations. Historically, this care model has reduced readmission rates by 44% and hospital stay lengths by 35%.
Amedisys, Inc. (NASDAQ: AMED) announced the acquisition of home health assets from AssistedCare Home Health, enhancing its services in North Carolina. The deal, set to close on or around April 1, 2022, will allow Amedisys to serve over 1.5 million Medicare enrollees in the state. AssistedCare's home health operations will transition to Amedisys, promoting a strategy focused on aging in place. Post-acquisition, Amedisys will encompass 350 care centers across 34 states, with approximately 74,000 daily patients, significantly expanding its community reach.
FAQ
What is the current stock price of Amedisys (AMED)?
What is the market cap of Amedisys (AMED)?
What services does Amedisys Inc. provide?
Where is Amedisys Inc. headquartered?
How many employees does Amedisys have?
What is the scope of Amedisys's operations?
How many patients does Amedisys serve annually?
What recent merger has Amedisys entered into?
What recent technological advancement has Amedisys incorporated?
What was Amedisys's net service revenue for Q1 2024?
How does Amedisys coordinate patient care?
What was the Personal Care segment of Amedisys?
